METHENAMINE HIPPURATE Drug Patent Profile
✉ Email this page to a colleague
When do Methenamine Hippurate patents expire, and what generic alternatives are available?
Methenamine Hippurate is a drug marketed by Aurobindo Pharma Ltd, Impax Labs Inc, Lyrus Life Sciences, Micro Labs, and Novast Labs. and is included in five NDAs.
The generic ingredient in METHENAMINE HIPPURATE is methenamine hippurate. There are ten drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the methenamine hippurate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Methenamine Hippurate
A generic version of METHENAMINE HIPPURATE was approved as methenamine hippurate by AUROBINDO PHARMA LTD on July 5th, 2016.
Summary for METHENAMINE HIPPURATE
| US Patents: | 0 |
| Applicants: | 5 |
| NDAs: | 5 |
| Finished Product Suppliers / Packagers: | 6 |
| Raw Ingredient (Bulk) Api Vendors: | 48 |
| Clinical Trials: | 6 |
| Patent Applications: | 2,144 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for METHENAMINE HIPPURATE |
| What excipients (inactive ingredients) are in METHENAMINE HIPPURATE? | METHENAMINE HIPPURATE excipients list |
| DailyMed Link: | METHENAMINE HIPPURATE at DailyMed |
Recent Clinical Trials for METHENAMINE HIPPURATE
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| University of Texas Southwestern Medical Center | Phase 4 |
| Washington University School of Medicine | Phase 4 |
| University of Oslo | Phase 4 |
Medical Subject Heading (MeSH) Categories for METHENAMINE HIPPURATE
Anatomical Therapeutic Chemical (ATC) Classes for METHENAMINE HIPPURATE
US Patents and Regulatory Information for METHENAMINE HIPPURATE
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Aurobindo Pharma Ltd | METHENAMINE HIPPURATE | methenamine hippurate | TABLET;ORAL | 205661-001 | Jul 5, 2016 | AB | RX | No | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Micro Labs | METHENAMINE HIPPURATE | methenamine hippurate | TABLET;ORAL | 212172-001 | Aug 1, 2019 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Impax Labs Inc | METHENAMINE HIPPURATE | methenamine hippurate | TABLET;ORAL | 076411-001 | Jun 20, 2003 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Lyrus Life Sciences | METHENAMINE HIPPURATE | methenamine hippurate | TABLET;ORAL | 217675-001 | Dec 1, 2023 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| Novast Labs | METHENAMINE HIPPURATE | methenamine hippurate | TABLET;ORAL | 210068-001 | Nov 27, 2020 | AB | RX | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
